Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This locus (ENSG00000259600) represents a pseudogene related to the functional mitochondrial gene MT-ND4L, which encodes a protein subunit of mitochondrial respiratory Complex I. Pseudogenes do not produce functional proteins and are typically non-coding remnants of ancestral genes. There is no evidence for this locus being a receptor, enzyme, transporter, or any functional therapeutic target. Its presence is mainly of genomic and evolutionary interest, without direct biological function, disease association, or drug targeting relevance in current biomedical research[6]. Clarifying notes: - The confusion may arise because the canonical MT-ND4L gene is a mitochondrial genome-encoded subunit of Complex I that is clinically relevant (e.g., associated with Leber hereditary optic neuropathy), but ENSG00000259600 and the provided aliases refer to a nuclear-encoded pseudogene homolog of MT-ND4L, which is not a functional target[1][2][6]. - This target should not be used in the context of drug discovery or therapeutic research, as it does not encode a functional protein and lacks established roles in human biology or disease[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L pseudogene 23 (MTND4LP23).